These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 25687208

  • 1. Vulval Crohn's disease: a clinical study of 22 patients.
    Laftah Z, Bailey C, Zaheri S, Setterfield J, Fuller LC, Lewis F.
    J Crohns Colitis; 2015 Apr; 9(4):318-25. PubMed ID: 25687208
    [Abstract] [Full Text] [Related]

  • 2. Crohn's disease of the vulva: A prospective study.
    Bhoyrul B, Lyon C.
    J Gastroenterol Hepatol; 2018 Dec; 33(12):1969-1974. PubMed ID: 29845642
    [Abstract] [Full Text] [Related]

  • 3. Clinical experience and diagnostic algorithm of vulval Crohn's disease.
    Boxhoorn L, Stoof TJ, de Meij T, Hoentjen F, Oldenburg B, Bouma G, Löwenberg M, van Bodegraven AA, de Boer NKH, Dutch Initiative on Crohn and Colitis.
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):838-843. PubMed ID: 28430699
    [Abstract] [Full Text] [Related]

  • 4. Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails?
    Lakatos PL.
    Rev Recent Clin Trials; 2009 Sep; 4(3):152-8. PubMed ID: 20028325
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of vulval Crohn's disease with infliximab.
    Preston PW, Hudson N, Lewis FM.
    Clin Exp Dermatol; 2006 May; 31(3):378-80. PubMed ID: 16681581
    [Abstract] [Full Text] [Related]

  • 8. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis.
    Hazlewood GS, Rezaie A, Borman M, Panaccione R, Ghosh S, Seow CH, Kuenzig E, Tomlinson G, Siegel CA, Melmed GY, Kaplan GG.
    Gastroenterology; 2015 Feb; 148(2):344-54.e5; quiz e14-5. PubMed ID: 25448924
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adalimumab as second line anti-tumour necrosis factor alpha therapy for Crohn's disease: A single centre experience.
    Sprakes MB, Hamlin PJ, Warren L, Greer D, Ford AC.
    J Crohns Colitis; 2011 Aug; 5(4):324-31. PubMed ID: 21683302
    [Abstract] [Full Text] [Related]

  • 14. [Severe lymphopenia in a patient with Crohn's disease].
    Monasterio C, Kreisel W, Hasselblatt P.
    Internist (Berl); 2018 Aug; 59(8):857-860. PubMed ID: 29356833
    [Abstract] [Full Text] [Related]

  • 15. Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.
    Karmiris K, Bossuyt P, Sorrentino D, Moreels T, Scarcelli A, Legido J, Dotan I, Naismith GD, Jussila A, Preiss JC, Kruis W, Li AC, Bouguen G, Yanai H, Steinwurz F, Katsanos KH, Subramaniam K, Tarabar D, Zaganas IV, Ben-Horin S, ECCO CONFER investigators.
    J Crohns Colitis; 2015 May; 9(5):382-9. PubMed ID: 25740813
    [Abstract] [Full Text] [Related]

  • 16. Azathioprine discontinuation earlier than 6 months in Crohn's disease patients started on anti-TNF therapy is associated with loss of response and the need for anti-TNF dose escalation.
    Viazis N, Koukouratos T, Anastasiou J, Giakoumis M, Triantos C, Tsolias C, Theocharis G, Karamanolis DG.
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):436-41. PubMed ID: 25874518
    [Abstract] [Full Text] [Related]

  • 17. Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn's disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course.
    Harris RE, Aloi M, de Ridder L, Croft NM, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Bigot L, Ruemmele FM, Russell RK, PIBD SETQuality consortium and PIBDnet.
    BMJ Open; 2020 Jul 01; 10(7):e034892. PubMed ID: 32611737
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Crohn's disease of the vulva.
    Barret M, de Parades V, Battistella M, Sokol H, Lemarchand N, Marteau P.
    J Crohns Colitis; 2014 Jul 01; 8(7):563-70. PubMed ID: 24252167
    [Abstract] [Full Text] [Related]

  • 20. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec 01; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.